Regulatory de-risking Jordi Labs specializes in regulator-credible testing, E&L studies, toxicology risk assessments, and regulatory consulting, offering a strong value proposition for MedTech companies facing submission challenges and post-market questions.

End-to-end strengths As part of RQM+, Jordi Labs combines laboratory science with regulatory, quality, clinical, and reimbursement expertise, enabling one-stop support from development through post-market to reduce surprises and accelerate time-to-market.

Post-market integration Recent partnerships with PMCF and real-world evidence platforms like 3Aware indicate a strategic emphasis on post-market surveillance and data-driven ongoing compliance, presenting cross-sell opportunities to customers needing PMCF optimization.

Technology modernized Adoption of digital tools (HubSpot Analytics, Google Cloud, DocuSign, fern.ai) and collaborative platforms suggests potential for offering scalable, SaaS-enabled services, automated reporting, and streamlined regulatory submissions.

Growth signals mid-market funding signals and revenue in the $100M–$250M range, along with leadership changes and SMART Solutions initiative, point to a growing, investable MedTech CRO with capacity for expanded service lines and cross-selling with large device manufacturers.